Investigative Ophthalmology & Visual Science, Vol 37, 2504-2518, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1

C Takagi, SE Bursell, YW Lin, H Takagi, E Duh, Z Jiang, AC Clermont and GL King
Joslin Diabetes Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

PURPOSE: To investigate the role of endogenous endothelin-1 (ET-1) expression and its interaction with the ETA receptor in the physiologic regulation of vascular tone as well as in the development of abnormal retinal hemodynamics in diabetes. METHODS: Retinal blood flow, using digitized video fluorescein angiography recordings, was quantitated after intravitreous injections of ET-1; BQ-123, an ETA receptor antagonist; and phosporamindon, an endothelin converting enzyme inhibitor in the eyes of diabetic and nondiabetic rats. A total of 154 rats were used for these experiments. Message levels of preproendothelin-1 (preproET-1) were measured from the retina of diabetic and nondiabetic rats using competitive polymerase chain reaction (PCR) techniques. RESULTS: Retinal blood flow was reduced (33%, P < 0.001) in diabetic rats compared to nondiabetic rats. BQ-123, an ETA receptor antagonist, but not saralasin, an angiotensin receptor antagonist, increased retinal blood flow in a dose-dependent manner in diabetic (EC50 of 8 x 10(-7) M) and in nondiabetic rats (EC50 of 8 x 10(-8) M). Besides being resistant to BQ-123, the maximal response in diabetic animals occurred 20 minutes later than in nondiabetic animals. Decreasing ET-1 levels by inhibiting endothelin-converting enzyme with phosphoramidon normalized retinal blood flow in diabetic rats. In nondiabetic rats, the intravitreous injection of exogenous ET-1 (10(-8) M) resulted in retinal blood flow decreases comparable to those measured in diabetic animals, and the subsequent injection of 10(-4) M BQ-123 produced retinal blood flow changes comparable to those measured in BQ-123 injected diabetic rats. Comparison of preproET-1 messenger RNA expression in the retina, brain and lung of control and diabetic rats using quantitative PCR and Northern blot analysis showed 2.0- and 1.7-fold increases in the retina and the brain, respectively, without changes in the lung. CONCLUSIONS: These data suggest that ET-1 is involved in the regulation of retinal blood flow in normal physiologic outcome, and an increase in the endogenous expression of ET-1 contributes to the reduction of retinal blood flow reported in the early stages of diabetes mellitus.

This article has been cited by other articles:

				N. Izumi, T. Nagaoka, E. Sato, K. Sogawa, H. Kagokawa, A. Takahashi, A. Kawahara, and A. Yoshida Role of Nitric Oxide in Regulation of Retinal Blood Flow in Response to Hyperoxia in Cats Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4595 - 4603. [Abstract] [Full Text] [PDF]

				M. K. McGahon, D. P. Dash, A. Arora, N. Wall, J. Dawicki, D. A. Simpson, C. N. Scholfield, J. G. McGeown, and T. M. Curtis Diabetes Downregulates Large-Conductance Ca2+-Activated Potassium {beta}1 Channel Subunit in Retinal Arteriolar Smooth Muscle Circ. Res., March 16, 2007; 100(5): 703 - 711. [Abstract] [Full Text] [PDF]

				S.-F. Yan, E. Harja, M. Andrassy, T. Fujita, and A. M. Schmidt Protein Kinase C {beta}/Early Growth Response-1 Pathway: A Key Player in Ischemia, Atherosclerosis, and Restenosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A47 - A55. [Abstract] [Full Text] [PDF]

				R. Roberts, H. Luan, and B. A. Berkowitz Blocking ET-1 Receptors Does Not Correct Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3550 - 3555. [Abstract] [Full Text] [PDF]

				K. Masuzawa, S. Jesmin, S. Maeda, S. Zaedi, N. Shimojo, T. Miyauchi, and K. Goto Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Experimental Biology and Medicine, June 1, 2006; 231(6): 1090 - 1094. [Abstract] [Full Text] [PDF]

				K. Matsushita and D. G. Puro Topographical heterogeneity of KIR currents in pericyte-containing microvessels of the rat retina: effect of diabetes J. Physiol., June 1, 2006; 573(2): 483 - 495. [Abstract] [Full Text] [PDF]

				A. Luksch, B. Wimpissinger, K. Polak, K. Jandrasits, and L. Schmetterer ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1693 - H1698. [Abstract] [Full Text] [PDF]

				E. D. Gilmore, C. Hudson, S. T. Venkataraman, D. Preiss, and J. Fisher Comparison of Different Hyperoxic Paradigms to Induce Vasoconstriction: Implications for the Investigation of Retinal Vascular Reactivity Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3207 - 3212. [Abstract] [Full Text] [PDF]

				R Donnelly, I Idris, and J V Forrester Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research Br. J. Ophthalmol., January 1, 2004; 88(1): 145 - 151. [Abstract] [Full Text] [PDF]

				T. Abiko, A. Abiko, A. C. Clermont, B. Shoelson, N. Horio, J. Takahashi, A. P. Adamis, G. L. King, and S.-E. Bursell Characterization of Retinal Leukostasis and Hemodynamics in Insulin Resistance and Diabetes: Role of Oxidants and Protein Kinase-C Activation Diabetes, March 1, 2003; 52(3): 829 - 837. [Abstract] [Full Text] [PDF]

				T. Yokota, R. C. Ma, J.-Y. Park, K. Isshiki, K. B. Sotiropoulos, R. K. Rauniyar, K. E. Bornfeldt, and G. L. King Role of Protein Kinase C on the Expression of Platelet-Derived Growth Factor and Endothelin-1 in the Retina of Diabetic Rats and Cultured Retinal Capillary Pericytes Diabetes, March 1, 2003; 52(3): 838 - 845. [Abstract] [Full Text] [PDF]

				H Er, C Evereklioglu, T Cumurcu, Y Turkoz, E Ozerol, K Sahin, and S Doganay Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease Br. J. Ophthalmol., June 1, 2002; 86(6): 653 - 657. [Abstract] [Full Text] [PDF]

				H. Kawamura, H. Oku, Q. Li, K. Sakagami, and D. G. Puro Endothelin-Induced Changes in the Physiology of Retinal Pericytes Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 882 - 888. [Abstract] [Full Text] [PDF]

				K. Polak, V. Petternel, A. Luksch, J. Krohn, O. Findl, E. Polska, and L. Schmetterer Effect of Endothelin and BQ123 on Ocular Blood Flow Parameters in Healthy Subjects Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2949 - 2956. [Abstract] [Full Text] [PDF]

				A. M. Joussen, S. Huang, V. Poulaki, K. Camphausen, W.-D. Beecken, B. Kirchhof, and A. P. Adamis In Vivo Retinal Gene Expression in Early Diabetes Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3047 - 3057. [Abstract] [Full Text] [PDF]

				F. Mori, G. L. King, A. C. Clermont, D. K. Bursell, and S.-E. Bursell Endothelin-3 Regulation of Retinal Hemodynamics in Nondiabetic and Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3955 - 3962. [Abstract] [Full Text]

				M. Meier and G. L King Protein kinase C activation and its pharmacological inhibition in vascular disease Vascular Medicine, August 1, 2000; 5(3): 173 - 185. [Abstract] [PDF]

				K. Naruse and G. L. King Protein Kinase C and Myocardial Biology and Function Circ. Res., June 9, 2000; 86(11): 1104 - 1106. [Full Text] [PDF]

				A. McGinty, C. N. Scholfield, W.-H. Liu, P. Anderson, D. E. E. Hoey, and E. R. Trimble Effect of Glucose on Endothelin-1-induced Calcium Transients in Cultured Bovine Retinal Pericytes J. Biol. Chem., September 3, 1999; 274(36): 25250 - 25253. [Abstract] [Full Text] [PDF]

				A. Iannaccone, C. Letizia, S. Pazzaglia, E. M Vingolo, G. Clemente, and M. R Pannarale Plasma endothelin-1 concentrations in patients with retinal vein occlusions Br. J. Ophthalmol., May 1, 1998; 82(5): 498 - 503. [Abstract] [Full Text]